ATE300520T1 - Verfahren zur herstellung amlodipinmaleat - Google Patents
Verfahren zur herstellung amlodipinmaleatInfo
- Publication number
- ATE300520T1 ATE300520T1 AT01972796T AT01972796T ATE300520T1 AT E300520 T1 ATE300520 T1 AT E300520T1 AT 01972796 T AT01972796 T AT 01972796T AT 01972796 T AT01972796 T AT 01972796T AT E300520 T1 ATE300520 T1 AT E300520T1
- Authority
- AT
- Austria
- Prior art keywords
- amlodipinmaleate
- producing
- producing amlodipinmaleate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25861200P | 2000-12-29 | 2000-12-29 | |
US80934301A | 2001-03-16 | 2001-03-16 | |
PCT/NL2001/000607 WO2002053542A1 (en) | 2000-12-29 | 2001-08-15 | Process for making amlodipine maleate |
BE2001/0709A BE1014452A6 (nl) | 2000-12-29 | 2001-11-05 | Werkwijze voor het maken van amlodipinemaleaat. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE300520T1 true ATE300520T1 (de) | 2005-08-15 |
Family
ID=29740325
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01972796T ATE300520T1 (de) | 2000-12-29 | 2001-08-15 | Verfahren zur herstellung amlodipinmaleat |
AT0093403U AT7109U3 (de) | 2000-12-29 | 2003-12-29 | Verfahren zur herstellung von amlodipinmaleat |
AT0093503U AT7110U9 (de) | 2000-12-29 | 2003-12-29 | Verfahren zur herstellung von amlodipinmaleat |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0093403U AT7109U3 (de) | 2000-12-29 | 2003-12-29 | Verfahren zur herstellung von amlodipinmaleat |
AT0093503U AT7110U9 (de) | 2000-12-29 | 2003-12-29 | Verfahren zur herstellung von amlodipinmaleat |
Country Status (25)
Country | Link |
---|---|
US (2) | US6600047B2 (de) |
EP (1) | EP1309555B1 (de) |
CN (1) | CN1272319C (de) |
AP (1) | AP2003002820A0 (de) |
AT (3) | ATE300520T1 (de) |
BE (1) | BE1014452A6 (de) |
BR (1) | BR0116557A (de) |
CA (1) | CA2433288C (de) |
DE (2) | DE60112305T2 (de) |
DK (3) | DK1309555T3 (de) |
ES (1) | ES2243553T3 (de) |
FI (1) | FI6788U1 (de) |
HK (2) | HK1055965A1 (de) |
HR (1) | HRP20030526A2 (de) |
IL (1) | IL156692A0 (de) |
IS (1) | IS6834A (de) |
MA (1) | MA25984A1 (de) |
MX (1) | MXPA03005885A (de) |
NO (1) | NO20032518L (de) |
NZ (1) | NZ526506A (de) |
PL (1) | PL362660A1 (de) |
PT (1) | PT1309555E (de) |
RS (1) | RS53403A (de) |
SI (1) | SI1309555T1 (de) |
WO (1) | WO2002053542A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2433191A1 (en) * | 2000-12-29 | 2002-07-11 | Pfizer Limited | Aspartate derivative of amlodipine as calcium channel antagonist |
BR0116554A (pt) * | 2000-12-29 | 2004-02-03 | Pfizer Ltd | Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão |
DE60112305T2 (de) * | 2000-12-29 | 2006-05-24 | Pfizer Ltd., Sandwich | Verfahren zur herstellung amlodipinmaleat |
MXPA03005882A (es) * | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Derivado amida de amlodipina. |
US6653481B2 (en) * | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
US20030027848A1 (en) * | 2001-06-15 | 2003-02-06 | Anne Billotte | Stabilized formulations |
GB0114709D0 (en) * | 2001-06-15 | 2001-08-08 | Pfizer Ltd | Stabilised formulations of amlodipine maleate |
US20030180354A1 (en) * | 2001-10-17 | 2003-09-25 | Dr. Reddy's Laboratories Limited | Amlodipine maleate formulations |
KR100538641B1 (ko) * | 2002-07-30 | 2005-12-22 | 씨제이 주식회사 | 암로디핀의 유기산염 |
KR100496436B1 (ko) | 2002-07-30 | 2005-06-20 | 씨제이 주식회사 | 암로디핀의 유기산염 |
KR100467669B1 (ko) * | 2002-08-21 | 2005-01-24 | 씨제이 주식회사 | 암로디핀의 유기산염 |
AU2003253460A1 (en) * | 2002-09-19 | 2004-04-08 | Cj Corporation | Crystalline organic acid salt of amlodipine |
EP1407773A1 (de) * | 2002-10-08 | 2004-04-14 | Council of Scientific and Industrial Research | Verfahren zur Herstellung von s(-)Amlodipin-Salzen |
US20040072879A1 (en) * | 2002-10-10 | 2004-04-15 | Dr. Reddy's Laboratories Limited | Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine) |
AU2002368531A1 (en) * | 2002-12-30 | 2004-07-22 | Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. | Isolation of dihydropyridine derivative and preparation salts thereof |
WO2005023769A1 (en) * | 2003-09-04 | 2005-03-17 | Cipla Limited | Process for the preparation of amlodipine salts |
EP1687273A1 (de) * | 2003-11-20 | 2006-08-09 | Council Of Scientific And Industrial Research | Verfahren zur herstellung chiraler amlodipinsalze |
US20060035940A1 (en) * | 2004-03-16 | 2006-02-16 | Sepracor Inc. | (S)-Amlodipine malate |
PT2077995E (pt) * | 2006-11-02 | 2012-05-10 | Millennium Pharm Inc | Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa |
KR100843400B1 (ko) * | 2006-11-14 | 2008-07-04 | 씨제이제일제당 (주) | 결정성 s-(-)-암로디핀 말레익산 염 무수물 및 이의제조방법 |
US20090062352A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched amlodipine |
CN102344409B (zh) * | 2011-07-20 | 2013-04-03 | 海南锦瑞制药股份有限公司 | 一种氨氯地平晶体、其与贝那普利药用组合物及制备方法 |
CN102382041B (zh) * | 2011-12-02 | 2016-01-20 | 东北制药集团股份有限公司 | 一种马来酸氨氯地平的制备方法 |
CN103044314A (zh) * | 2013-01-06 | 2013-04-17 | 先声药业有限公司 | 马来酸氨氯地平的制备方法 |
CN104529877A (zh) * | 2015-01-22 | 2015-04-22 | 华东理工常熟研究院有限公司 | 氨氯地平-癸酸离子液体及其制备方法和用途 |
ES2886067T3 (es) | 2016-10-07 | 2021-12-16 | Silvergate Pharmaceuticals Inc | Formulaciones de amlodipina |
CN108358833A (zh) * | 2018-03-15 | 2018-08-03 | 上海峰林生物科技有限公司 | 一种马来酸氨氯地平的合成工艺 |
CA3096101A1 (en) | 2018-04-11 | 2019-10-17 | Silvergate Pharmaceuticals, Inc. | Amlodipine formulations |
CN109651236A (zh) * | 2019-01-24 | 2019-04-19 | 浙江尖峰药业有限公司 | 门冬氨酸氨氯地平的晶型及其制备和应用 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4294969A (en) * | 1979-01-29 | 1981-10-13 | Merck & Co., Inc. | Process for producing 2-bromo-3,5-disubstituted pyridines |
CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
DK161312C (da) | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
GR851819B (de) * | 1984-08-17 | 1985-11-26 | Wyeth John & Brother Ltd | |
IT1201454B (it) * | 1985-08-19 | 1989-02-02 | Boehringer Biochemia Srl | 1,4-diidropiridine-2-sostituite |
GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
FR2602231B1 (fr) * | 1986-08-04 | 1988-10-28 | Adir | Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
US4983740A (en) | 1986-08-04 | 1991-01-08 | Adir Et Compagnie | Process for 1,4-dihydropyridine compounds |
GB8710493D0 (en) | 1987-05-02 | 1987-06-03 | Pfizer Ltd | Dihydropyridines |
US5155120A (en) | 1991-01-14 | 1992-10-13 | Pfizer Inc | Method for treating congestive heart failure |
WO1993006082A1 (en) | 1991-09-13 | 1993-04-01 | Merck & Co., Inc. | Process for the preparation of 4-substituted-1,4-dihydropyridines |
US5389654A (en) | 1992-11-26 | 1995-02-14 | Lek, Tovarna, Farmacevtskih In Kemicnih . . . | 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate |
HU221810B1 (hu) | 1997-08-12 | 2003-01-28 | EGIS Gyógyszergyár Rt. | Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei |
ZA9810320B (en) | 1997-11-14 | 2000-05-11 | Gea Farmaceutisk Fabrik As | Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose. |
ZA9810319B (en) * | 1997-11-14 | 2000-05-11 | Gea Farmaceutisk Fabrik As | Process for the preparation of acetal derivatives of 1,4-dihydropyridines, novel acetal derivatives and the use of the acetal derivatives for the preparation of other 1,4-dihydropyridines. |
PL189666B1 (pl) * | 1998-04-09 | 2005-09-30 | Adamed Sp Z Oo | Sposób otrzymywania benzenosulfonianu amlodypiny |
GB9812413D0 (en) | 1998-06-10 | 1998-08-05 | Glaxo Group Ltd | Compound and its use |
ES2151850B1 (es) | 1998-10-26 | 2001-08-16 | Esteve Quimica Sa | Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente. |
GB9827387D0 (en) | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel process |
GB9827431D0 (en) | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel compound |
CA2433191A1 (en) * | 2000-12-29 | 2002-07-11 | Pfizer Limited | Aspartate derivative of amlodipine as calcium channel antagonist |
DE60112305T2 (de) | 2000-12-29 | 2006-05-24 | Pfizer Ltd., Sandwich | Verfahren zur herstellung amlodipinmaleat |
BR0116552A (pt) * | 2000-12-29 | 2004-02-03 | Pfizer Ltd | Hemi-maleato de amlodipina, processo, método para o tratamento ou prevenção de angina ou hipertensão, composição farmacêutica, para uso no tratamento e/ou de angina ou da hipertensão |
BR0116554A (pt) * | 2000-12-29 | 2004-02-03 | Pfizer Ltd | Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão |
EP1309556B1 (de) * | 2000-12-29 | 2004-11-24 | Pfizer Limited | Amlodipinfumarat |
-
2001
- 2001-08-15 DE DE60112305T patent/DE60112305T2/de not_active Revoked
- 2001-08-15 EP EP01972796A patent/EP1309555B1/de not_active Revoked
- 2001-08-15 CN CNB018215149A patent/CN1272319C/zh not_active Expired - Fee Related
- 2001-08-15 NZ NZ526506A patent/NZ526506A/en unknown
- 2001-08-15 ES ES01972796T patent/ES2243553T3/es not_active Expired - Lifetime
- 2001-08-15 DK DK01972796T patent/DK1309555T3/da active
- 2001-08-15 SI SI200130388T patent/SI1309555T1/sl unknown
- 2001-08-15 CA CA002433288A patent/CA2433288C/en not_active Expired - Fee Related
- 2001-08-15 BR BR0116557-7A patent/BR0116557A/pt not_active IP Right Cessation
- 2001-08-15 PL PL01362660A patent/PL362660A1/xx not_active Application Discontinuation
- 2001-08-15 AT AT01972796T patent/ATE300520T1/de not_active IP Right Cessation
- 2001-08-15 RS YU53403A patent/RS53403A/sr unknown
- 2001-08-15 IL IL15669201A patent/IL156692A0/xx unknown
- 2001-08-15 WO PCT/NL2001/000607 patent/WO2002053542A1/en active IP Right Grant
- 2001-08-15 PT PT01972796T patent/PT1309555E/pt unknown
- 2001-08-15 AP APAP/P/2003/002820A patent/AP2003002820A0/en unknown
- 2001-08-15 MX MXPA03005885A patent/MXPA03005885A/es not_active Application Discontinuation
- 2001-08-27 US US09/938,841 patent/US6600047B2/en not_active Expired - Fee Related
- 2001-09-25 DE DE20115704U patent/DE20115704U1/de not_active Ceased
- 2001-11-05 BE BE2001/0709A patent/BE1014452A6/nl not_active IP Right Cessation
-
2003
- 2003-05-08 US US10/431,539 patent/US20030199559A1/en not_active Abandoned
- 2003-05-27 MA MA27182A patent/MA25984A1/fr unknown
- 2003-05-30 IS IS6834A patent/IS6834A/is unknown
- 2003-06-04 NO NO20032518A patent/NO20032518L/no not_active Application Discontinuation
- 2003-06-27 HR HR20030526A patent/HRP20030526A2/xx not_active Application Discontinuation
- 2003-11-13 HK HK03108272A patent/HK1055965A1/xx not_active IP Right Cessation
- 2003-12-12 DK DK200300345U patent/DK200300345U3/da not_active IP Right Cessation
- 2003-12-12 DK DK200300344U patent/DK200300344U4/da not_active IP Right Cessation
- 2003-12-17 FI FI20030476U patent/FI6788U1/fi active IP Right Grant
- 2003-12-29 AT AT0093403U patent/AT7109U3/de not_active IP Right Cessation
- 2003-12-29 AT AT0093503U patent/AT7110U9/de not_active IP Right Cessation
-
2004
- 2004-10-05 HK HK04107618A patent/HK1064671A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE300520T1 (de) | Verfahren zur herstellung amlodipinmaleat | |
ATE386736T1 (de) | Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten | |
DE60221399D1 (de) | Verfahren zur herstellung von mitteldistillaten | |
DE60107450D1 (de) | Verfahren zur herstellung von fluoroelastomeren | |
ATE403641T1 (de) | Verfahren zur herstellung von o- desmethylvenlafaxin | |
DE50107437D1 (de) | Verfahren zur herstellung von polyacrylaten | |
DE60033061D1 (de) | Verfahren zur herstellung von siloxancopolycarbonaten | |
DE60102784D1 (de) | Verfahren zur herstellung von alkylaromaten | |
ATE281448T1 (de) | Verfahren zur herstellung von citalopram | |
DE60230908D1 (de) | Verfahren zur herstellung von polyarylenethern | |
DE60134650D1 (de) | Verfahren zur herstellung honigförmiger waben | |
ATE388026T1 (de) | Verfahren zur herstellung von oberflächenelementen | |
ATE331804T1 (de) | Verfahren zur herstellung von ansamitocin | |
DE60126336D1 (de) | Verfahren zur herstellung von hochreinen durchscheinenden perfluorelastomer-gegenständen | |
DE50101607D1 (de) | Verfahren zur herstellung von bisphenolen | |
DE50102444D1 (de) | Verfahren zur herstellung von isocyanatoorganosilanen | |
ATE316518T1 (de) | Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen | |
DE50111560D1 (de) | Verfahren zur herstellung von guerbetalkoholen | |
ATE287870T1 (de) | Verfahren zur herstellung von phenethylamin- derivaten | |
DE50211941D1 (de) | Verfahren zur Herstellung vergrabener Bereiche | |
ATE441662T1 (de) | Verfahren zur herstellung von echinocandinderivaten | |
DE60103173D1 (de) | Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin | |
DE60123824D1 (de) | Verfahren zur herstellung veresterter kondensate | |
ATE389645T1 (de) | Verfahren zur herstellung von citalopram | |
DE50200870D1 (de) | Verfahren zur herstellung von hydroxyalkylpolysiloxanen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1309555 Country of ref document: EP |
|
RZN | Patent revoked |